|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/06 | |
| C07D 403/06 | |||
| C07D 405/14 | |||
| A61K 31/454 | |||
| A61K 31/496 | |||
| A61P 3/00 |
| (11) | Patento numeris | 2010519 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07755189.3 |
| Europos patento paraiškos padavimo data | 2007-04-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-01-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-07-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/008832 |
| Data | 2007-04-10 |
| (87) | Numeris | WO 2007/120655 |
| Data | 2007-10-25 |
| (30) | Numeris | Data | Šalis |
| 791961 P | 2006-04-14 | US |
| (72) |
BERGER, Richard, US
EDMONDSON, Scott, US
HANSEN, Alexa, US
ZHU, Cheng, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (54) | SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS |
| SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS |